Fisher Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4B | Buy |
2,851,579
+59,158
| +2% | +$32.1M | 0.48% | 61 |
|
|
2025
Q4 | $1.62B | Buy |
2,792,421
+71,320
| +3% | +$40.3M | 0.55% | 48 |
|
|
2025
Q3 | $1.32B | Buy |
2,721,101
+31,298
| +1% | +$14.6M | 0.48% | 63 |
|
|
2025
Q2 | $1.09B | Sell |
2,689,803
-25,615
| -0.9% | -$10.7M | 0.43% | 72 |
|
|
2025
Q1 | $1.35B | Buy |
2,715,418
+49,516
| +2% | +$26.8M | 0.58% | 56 |
|
|
2024
Q4 | $1.39B | Buy |
2,665,902
+29,344
| +1% | +$16.1M | 0.55% | 48 |
|
|
2024
Q3 | $1.63B | Buy |
2,636,558
+65,586
| +3% | +$38.8M | 0.67% | 42 |
|
|
2024
Q2 | $1.42B | Buy |
2,570,972
+73,574
| +3% | +$42.1M | 0.62% | 50 |
|
|
2024
Q1 | $1.45B | Sell |
2,497,398
-74,268
| -3% | -$41.7M | 0.68% | 47 |
|
|
2023
Q4 | $1.37B | Buy |
2,571,666
+589
| +0% | +$285K | 0.72% | 40 |
|
|
2023
Q3 | $1.3B | Buy |
2,571,077
+114,394
| +5% | +$61M | 0.74% | 40 |
|
|
2023
Q2 | $1.28B | Buy |
2,456,683
+60,712
| +3% | +$32.8M | 0.71% | 35 |
|
|
2023
Q1 | $1.38B | Buy |
2,395,971
+44,874
| +2% | +$25.3M | 0.84% | 24 |
|
|
2022
Q4 | $1.29B | Buy |
2,351,097
+46,035
| +2% | +$24.4M | 0.88% | 28 |
|
|
2022
Q3 | $1.17B | Sell |
2,305,062
-35,752
| -2% | -$20M | 0.88% | 27 |
|
|
2022
Q2 | $1.27B | Buy |
2,340,814
+83,936
| +4% | +$46.2M | 0.9% | 28 |
|
|
2022
Q1 | $1.33B | Buy |
2,256,878
+104,324
| +5% | +$59.9M | 0.79% | 33 |
|
|
2021
Q4 | $1.44B | Buy |
2,152,554
+139,982
| +7% | +$87.4M | 0.8% | 29 |
|
|
2021
Q3 | $1.15B | Buy |
2,012,572
+86,150
| +4% | +$47.3M | 0.71% | 38 |
|
|
2021
Q2 | $972M | Buy |
1,926,422
+112,351
| +6% | +$53M | 0.61% | 47 |
|
|
2021
Q1 | $828M | Buy |
1,814,071
+82,766
| +5% | +$39.5M | 0.58% | 49 |
|
|
2020
Q4 | $806M | Buy |
1,731,305
+116,353
| +7% | +$54.6M | 0.6% | 49 |
|
|
2020
Q3 | $713M | Buy |
1,614,952
+85,254
| +6% | +$35.2M | 0.62% | 45 |
|
|
2020
Q2 | $554M | Buy |
1,529,698
+585,222
| +62% | +$196M | 0.54% | 51 |
|
|
2020
Q1 | $268M | Buy |
944,476
+942,774
| +55,392% | +$297M | 0.33% | 65 |
|
|
2019
Q4 | $553K | Buy |
1,702
+123
| +8% | +$37.3K | ﹤0.01% | 647 |
|
|
2019
Q3 | $460K | Buy |
1,579
+668
| +73% | +$191K | ﹤0.01% | 700 |
|
|
2019
Q2 | $268K | Buy |
+911
| New | +$251K | ﹤0.01% | 748 |
|
|
2019
Q1 | – | Sell |
-968
| Closed | -$217K | – | 854 |
|
|
2018
Q4 | $217K | Sell |
968
-825
| -46% | -$194K | ﹤0.01% | 754 |
|
|
2018
Q3 | $438K | Buy |
1,793
+73
| +4% | +$16.8K | ﹤0.01% | 667 |
|
|
2018
Q2 | $356K | Sell |
1,720
-190
| -10% | -$40.3K | ﹤0.01% | 679 |
|
|
2018
Q1 | $394K | Sell |
1,910
-160
| -8% | -$33.6K | ﹤0.01% | 649 |
|
|
2017
Q4 | $393K | Buy |
2,070
+805
| +64% | +$154K | ﹤0.01% | 681 |
|
|
2017
Q3 | $239K | Sell |
1,265
-19
| -1% | -$3.44K | ﹤0.01% | 723 |
|
|
2017
Q2 | $224K | Sell |
1,284
-1,318
| -51% | -$221K | ﹤0.01% | 699 |
|
|
2017
Q1 | $400K | Buy |
2,602
+895
| +52% | +$137K | ﹤0.01% | 583 |
|
|
2016
Q4 | $241K | Buy |
1,707
+225
| +15% | +$33.2K | ﹤0.01% | 653 |
|
|
2016
Q3 | $236K | Buy |
+1,482
| New | +$228K | ﹤0.01% | 659 |
|
|
2016
Q2 | – | Sell |
-1,642
| Closed | -$239K | – | 714 |
|
|
2016
Q1 | $239K | Sell |
1,642
-225
| -12% | -$30.2K | ﹤0.01% | 635 |
|
|
2015
Q4 | $265K | Buy |
+1,867
| New | +$249K | ﹤0.01% | 638 |
|
Other funds holding TMO
VCM
